Product NDC: | 64208-8234 |
Proprietary Name: | Gammaplex |
Non Proprietary Name: | HUMAN IMMUNOGLOBULIN G |
Active Ingredient(s): | 5 g/100mL & nbsp; HUMAN IMMUNOGLOBULIN G |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 64208-8234 |
Labeler Name: | Bio Products Laboratory Limited |
Product Type: | PLASMA DERIVATIVE |
FDA Application Number: | BLA125329 |
Marketing Category: | BLA |
Start Marketing Date: | 20101101 |
Package NDC: | 64208-8234-5 |
Package Description: | 1 BOTTLE, GLASS in 1 CARTON (64208-8234-5) > 50 mL in 1 BOTTLE, GLASS (64208-8234-1) |
NDC Code | 64208-8234-5 |
Proprietary Name | Gammaplex |
Package Description | 1 BOTTLE, GLASS in 1 CARTON (64208-8234-5) > 50 mL in 1 BOTTLE, GLASS (64208-8234-1) |
Product NDC | 64208-8234 |
Product Type Name | PLASMA DERIVATIVE |
Non Proprietary Name | HUMAN IMMUNOGLOBULIN G |
Dosage Form Name | SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20101101 |
Marketing Category Name | BLA |
Labeler Name | Bio Products Laboratory Limited |
Substance Name | HUMAN IMMUNOGLOBULIN G |
Strength Number | 5 |
Strength Unit | g/100mL |
Pharmaceutical Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] |